about
Novel epigenetic-based therapies useful in cardiovascular medicineEpigenetic Modifications, Alcoholic Brain and Potential Drug TargetsThe Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear StructureDioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liverDisagreement between two common biomarkers of global DNA methylationThe epigenetic paradigm in periodontitis pathogenesis.From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseasesα-Globin as a molecular target in the treatment of β-thalassemiaRestored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cellsEpigenetic regulation of drug metabolism and transportMathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival RatesNuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions.Identifying DNA methylation in a nanochannel.Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis.Modeling of signaling crosstalk-mediated drug resistance and its implications on drug combination.Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO).Proteomics of the periconception milieu.Epigenetics and its role in periodontal diseases: a state-of-the-art review.The role of matrix compliance on cell responses to drugs and toxins: towards predictive drug screening platforms.Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism.Alterations of Histone Modifications Contribute to Pregnane X Receptor-Mediated Induction of CYP3A4 by Rifampicin.Nuclear receptors and drug metabolism for the personalization of cancer therapy.Exercise and epigenetic inheritance of disease risk.Exposure of CCRF-CEM cells to acridone derivative 8a triggers tumor death via multiple mechanisms.DNA Methylation of ADME Genes.Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.New drug developments in psychosis: Challenges, opportunities and strategies.The pharmacoepigenetics of drug metabolism and transport in breast cancer: review of the literature and in silico analysis.Genetics of the human placenta: implications for toxicokinetics.Pharmacoepigenetics: an element of personalized therapy?Drug metabolism and liver disease: a drug-gene-environment interaction.A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma.Effect of uridine protecting groups on the diastereoselectivity of uridine-derived aldehyde 5'-alkynylation.New Targets for Schizophrenia Treatment beyond the Dopamine HypothesisEpigenetic regulation - contribution to herbicide resistance in weeds?
P2860
Q26765152-373BEBDE-5149-4517-A34C-B9E4C4858A80Q28079220-6E41829A-890F-4A08-9F20-A4A9CD080A76Q28084785-7C531CE0-D84C-4975-A54A-9C558F79B811Q28822387-5A9936CA-FF97-4F6C-AA10-855663CAC461Q28833594-2DAE86FB-47BB-45C2-89AA-49E6FCCF9D91Q30375023-7A8AAB24-0A10-423B-9DF2-CAA903C8C105Q35314161-CCA32DF2-5064-4BF1-AC60-09F4770DC59EQ35340073-D2265F3B-A754-4EB4-A223-79D5C3EAE3E7Q35836891-8F45484E-79CC-4F29-B7DE-8C758FE157BAQ36089684-D942FB7F-BAA6-4686-A882-8481C3574EB6Q36237931-019C1ACA-3424-4D30-91F3-F113172A6117Q36634818-B2AF7C15-7D4A-4CAC-84C4-BF485C58CB51Q37130938-5E718BA4-554D-4B59-967A-8A3AADD6F965Q37403577-67131399-B1B7-44B5-AD27-F2860E59C583Q37534907-C86CD07B-D60D-40B9-B9AF-57BD1F022DC0Q37665545-CEF4A953-5D6E-4865-A944-2C0B4C4058DFQ37689738-B0F36B8A-7EE7-41D3-BDEB-74540F8464D4Q38268959-046347FA-6C64-43FB-8E67-618685BEDDA4Q38270260-C542F2E6-601D-4DFE-91A7-4B0D4E9BB114Q38345322-177EB98B-51BF-4AEC-80A3-28E2DCFFD492Q38495057-36F525B2-50F5-4EB9-871C-D873D09CBDE0Q38533459-0F599665-3CBA-4488-BA30-BEE474A4037FQ38618627-D0EC236A-0AD8-4930-B6CE-F68988BEF0B0Q38702217-C35A0E6D-F78D-40FF-B77F-842C732BC16CQ38704025-5CEFCC65-9353-4589-9D78-9A96B415DF3CQ38735790-55735066-A59C-4595-B9A8-FCC6A1415CCFQ38794989-CE05F1C2-889C-45F8-A59A-C0645C71516CQ38802927-F2166FDA-8374-4ED0-BAB7-C7C784FF85B9Q38831370-E8B3F6BA-27AA-4AAD-873B-C367BBAC5B99Q38854876-B4F4B5C3-4E3F-4A70-9678-C668007FA2F0Q38908841-4966F94D-7E05-4096-A64D-853215B25BE1Q38926246-92582612-DAD9-4902-AC4A-C68EBC3798D1Q38937221-EF5F87A0-40D7-4AB2-9E35-9281A2C8DD6CQ38947803-B3418C82-4DE7-4ACF-B9ED-33942DA5FC5BQ39012550-90A55DDA-E8FC-4D5E-B7C4-7BAA9E8FECC7Q39037269-4E9B66E8-B740-4EDB-ACE7-38BF7F2E0EB8Q40690632-716C9E90-E028-4D81-88A5-0F2FF4AF9D46Q41334870-51B60E2A-36C0-4BD1-A6EC-8191C0C28C61Q41573540-4E3C4D59-9449-4181-BE4D-C79883DFFFFDQ45066981-193A27C3-1BA1-4600-83C6-2E7E10E97A13
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic mechanisms of importance for drug treatment.
@en
type
label
Epigenetic mechanisms of importance for drug treatment.
@en
prefLabel
Epigenetic mechanisms of importance for drug treatment.
@en
P1476
Epigenetic mechanisms of importance for drug treatment
@en
P2093
Magnus Ingelman-Sundberg
P304
P356
10.1016/J.TIPS.2014.05.004
P577
2014-07-01T00:00:00Z